Tilman Schlothauer
29Patents
5h-index
62Co-inventors
68Inventor score
Filing activity: Mar 27, 2012 → Nov 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8969526B2 | Antibody Fc variants | Emerging Cross-Sectional Technologies | 126 | Active |
| US10323089B2 | Anti-transferrin receptor antibodies with tailored affinity | Chemistry; Metallurgy | 24 | Active |
| US10011644B2 | Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof | Physics | 9 | Active |
| US11286300B2 | Humanized anti-human CD19 antibodies and methods of use | Chemistry; Metallurgy | 8 | Active |
| US11584793B2 | Anti-transferrin receptor antibodies with tailored affinity | Chemistry; Metallurgy | 7 | Active |
| US10287352B2 | Bispecific antibodies specific for PD1 and TIM3 | Chemistry; Metallurgy | 5 | Active |
| US11130810B2 | Bispecific antibodies specific for PD1 and TIM3 | Chemistry; Metallurgy | 4 | Active |
| US10683368B2 | Fc-region variants with modified FcRn-binding and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10434184B2 | Anti-TPBG antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10822402B2 | Humanized anti-tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9862763B2 | Humanized anti-tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11525007B2 | Antibody fab and Fc variants | Chemistry; Metallurgy | 2 | Active |
| US11091541B2 | Human FcRn-binding modified antibodies and methods of use | Chemistry; Metallurgy | 2 | Active |
| US12252533B2 | Anti-transferrin receptor antibodies with tailored affinity | Chemistry; Metallurgy | 1 | Active |
| US12398203B2 | Method for producing bispecific antibodies comprising a Y436A Fc-region mutation for improved protein A-binding | Chemistry; Metallurgy | 0 | Active |
| US12391757B2 | Bispecific antibodies specific for PD1 and TIM3 | Chemistry; Metallurgy | 0 | Active |
| US11572404B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11814409B2 | Fc-receptor based affinity chromatography | Chemistry; Metallurgy | 0 | Active |
| US11739142B2 | Bispecific anti-CCL2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11440942B2 | Complement factor based affinity chromatography | Physics | 0 | Active |
| US12264196B2 | Fc-receptor binding modified asymmetric antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12215152B2 | Humanized anti-human CD19 antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10899846B2 | Fc-region variants with modified FcRn- and protein A-binding properties | Chemistry; Metallurgy | 0 | Active |
| US12103967B2 | Bispecific anti-CCL2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12297263B2 | Humanized anti-Tau(PS422) antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.